Virbac S.A.
VIRP
Rang in Aktien
#4514
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent... Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Aktienkurs
$408.63
Zuletzt synchronisiert: 2026-10-20
Marktkapitalisierung
$3.42B
Veränderung (1 Tag)
2.23%
Veränderung (1 Jahr)
-0.91%
Land
FR
Handel Virbac S.A. (VIRP)
Kategorie
Healthcare
Gewinn für Virbac S.A. (VIRP)
Gewinn im Jun 2026 TTM: $265.58M
Laut den aktuellen Finanzberichten von Virbac S.A. betragen die aktuellen Gewinne des Unternehmens $265.58M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $192.52M, eine Steigerung gegenüber dem Gewinn im Jahr 2022, der $189.27M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Virbac S.A. von 2002 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $265.58M | 22.55% |
| 2024 | $216.71M | 12.56% |
| 2023 | $192.52M | 1.72% |
| 2022 | $189.27M | 10.86% |
| 2021 | $170.73M | -19.12% |
| 2020 | $211.09M | 141.63% |
| 2019 | $87.36M | 83.84% |
| 2018 | $47.52M | -3.41% |
| 2017 | $49.20M | -11.53% |
| 2016 | $55.61M | 250.68% |
| 2015 | $15.86M | -86.85% |
| 2014 | $120.60M | -7.42% |
| 2013 | $130.28M | 3.46% |
| 2012 | $125.92M | 16.49% |
| 2011 | $108.09M | -6.13% |
| 2010 | $115.16M | 42.50% |
| 2009 | $80.81M | 15.08% |
| 2008 | $70.22M | -0.38% |
| 2007 | $70.49M | 41.66% |
| 2006 | $49.76M | 37.75% |
| 2005 | $36.13M | 5.39% |
| 2004 | $34.28M | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $33.60B | 12,550.12% |
US
|
|
| $17.74B | 6,578.71% |
US
|
|
| $8.70B | 3,175.53% |
US
|
|
| $5.95B | 2,139.67% |
US
|
|
| $21.39B | 7,953.57% |
CH
|
